COVID-19 Therapies | sciencenewsnet.in

Breaking News

Roy Choi Will Speak to Cal State Fullerton’s Class of 2024

Compact quantum light processing

Researchers develop a new way to safely boost immune cells to fight cancer

Alcohol-Induced Blackouts May Be Linked to How a Person Drinks, Not Just How Much

Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms

American College of Physicians issues clinical recommendations for newer pharmacological treatments of adults with Type 2 diabetes

RCT finds calories may be more important than meal timing when it comes to weight loss

Newer antibiotics underprescribed for highly resistant infections

Chula Ranks No.1 in Thailand for 32 Subjects in the QS World University Rankings by Subject 2024

Researchers to share expertise at international conference on mine water, reclamation

20 Apr, 2024

Houston Methodist and U.S. Department of Health and Human Services partner to expand access to COVID-19 monoclonal antibody treatment

May 27, 2021 sarah JonasAnnouncement

Houston Methodist announced today, in partnership with the U.S. Department of Health and Human Services (HHS), that it has expanded access to COVID-19 monoclonal antibody therapy (mAb) in the Greater Houston area. The promising treatment has been shown to keep high-risk COVID-19 patients out of the hospital and reduce the likelihood of progression to severe disease.